Screener
DiaMedica Therapeutics DMAC Q4 2025 Annual earnings
Reported March 30, 2026 · After market close
EPS-$0.17In line
EPS estimate-$0.17
Next report
Nov 11, 2026 (in 2 months)Revenue estimate$13.5M
EPS estimate-$0.20
Versus estimates
Diluted EPS
FAQ
- When did DiaMedica Therapeutics report Q4 2025 earnings?
- DiaMedica Therapeutics (DMAC) reported Q4 2025 earnings on March 30, 2026 after market close.
- What were DiaMedica Therapeutics's Q4 2025 revenue and EPS?
- DiaMedica Therapeutics reported eps of $-0.17 for Q4 2025.
- Did DiaMedica Therapeutics beat estimates in Q4 2025?
- EPS beat the consensus estimate of $-0.17 by $0.00.
- How did DiaMedica Therapeutics's Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 5.6% from $-0.18.
- Where can I find DiaMedica Therapeutics's Q4 2025 SEC filings?
- You can read the 8-K earnings release (0001437749-26-010409) and the 10-K periodic report (0001437749-26-010342) directly on SEC EDGAR. The filing index links above go to sec.gov.
